%0 Journal Article %T When better still might not be good enough %A Debinski, Waldemar %J Translational Cancer Research %D 2017 %B 2017 %9 %! When better still might not be good enough %K %X Immunotherapy has brought, arguably, the biggest advances in cancer treatment in recent years. Cancer immunotherapy can be divided into active and passive approaches. For example, vaccines are an active immunotherapy where the patient’s own immune system is mobilized to fight malignancy. On the other hand, passive immunotherapy relies on administering the effector arms of the immune system like antibodies or T cells. %U https://tcr.amegroups.org/article/view/16322 %P S1244-S1247 %@ 2219-6803